These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 33709991)

  • 1. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
    Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
    Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age Determines Adjuvant Chemotherapy Use in Resected Stage II Colon Cancer.
    Hagerty BL; Aversa JG; Dominguez DA; Davis JL; Hernandez JM; McCormick JT; Blakely AM
    Dis Colon Rectum; 2022 Oct; 65(10):1206-1214. PubMed ID: 34897212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Validity of Tumor-Informed Circulating Tumor DNA Analysis in Patients Undergoing Surgery of Colorectal Metastases.
    Hofste LSM; Geerlings MJ; Kamping EJ; Kouwenhoven NDH; von Rhein D; Jansen EAM; Garms LM; Nagtegaal ID; van der Post RS; de Wilt JHW; Klarenbeek BR; Ligtenberg MJL
    Dis Colon Rectum; 2023 Jun; 66(6):796-804. PubMed ID: 35857852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Work Ability in Patients With Stage I to IV Colon Cancer: Results of the Dutch Prospective Colorectal Cancer Cohort.
    Franken MD; Vink G; van Grevenstein WMU; Verkooijen HM; Punt CJA; Koopman M; May AM;
    Dis Colon Rectum; 2023 Jan; 66(1):50-58. PubMed ID: 34753892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Tumor-Related Complications Among Patients With Unresectable Stage IV Colorectal Cancer in the Era of Targeted Therapy: A Competing Risk Regression Analysis.
    Tanabe T; Shida D; Boku N; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Sep; 64(9):1074-1082. PubMed ID: 34397558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinicopathological Feature-Based Nomogram for Predicting the Likelihood of D3 Lymph Node Metastasis in Right-Sided Colon Cancer Patients.
    Long C; Feng M; Wang S; Ji H; Li Z; Zheng J; Jiang W; Yan J
    Dis Colon Rectum; 2023 Jan; 66(1):75-86. PubMed ID: 34897214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naples Prognostic Score Is a Useful Prognostic Marker in Patients With Metastatic Colorectal Cancer.
    Miyamoto Y; Hiyoshi Y; Daitoku N; Okadome K; Sakamoto Y; Yamashita K; Kuroda D; Sawayama H; Iwatsuki M; Baba Y; Yoshida N; Baba H
    Dis Colon Rectum; 2019 Dec; 62(12):1485-1493. PubMed ID: 31567920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of an Enhanced Recovery Protocol Is Associated With On-Time Initiation of Adjuvant Chemotherapy in Colorectal Cancer.
    Hassinger TE; Mehaffey JH; Martin AN; Bauer-Nilsen K; Turrentine FE; Thiele RH; Sarosiek BM; Reilley MJ; Hoang SC; Friel CM; Hedrick TL
    Dis Colon Rectum; 2019 Nov; 62(11):1305-1315. PubMed ID: 31567924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
    Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
    Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High World Heath Organization Performance Status Is Associated With Short- and Long-term Outcomes After Colorectal Cancer Surgery: A Nationwide Population-Based Study.
    Bojesen RD; Degett TH; Dalton SO; Gögenur I
    Dis Colon Rectum; 2021 Jul; 64(7):851-860. PubMed ID: 34086001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a Preoperative Leisure-Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I to III Colorectal Cancer: A Propensity Score Matching Analysis.
    You JF; Hsu YJ; Chern YJ; Hung HY; Hsieh PS; Yeh CY; Chiang JM; Tsai WS
    Dis Colon Rectum; 2020 Jun; 63(6):796-806. PubMed ID: 32118625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Prediction Model for Organ-Specific Recurrences After Curative Resection of Colon Cancer.
    Nagata H; Ishihara S; Oba K; Tanaka T; Hata K; Kawai K; Nozawa H
    Dis Colon Rectum; 2019 Sep; 62(9):1043-1054. PubMed ID: 31318776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in Surgical Outcomes Using 3-Dimensional Printed Models for Lateral Pelvic Lymph Node Dissection in Rectal Cancer.
    Hojo D; Murono K; Nozawa H; Kawai K; Hata K; Tanaka T; Oba K; Ishihara S
    Dis Colon Rectum; 2022 Apr; 65(4):566-573. PubMed ID: 34775410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased Tumoral Expression of Colon-Specific Water Channel Aquaporin 8 Is Associated With Reduced Overall Survival in Colon Adenocarcinoma.
    O'Brien SJ; Kalbfleisch T; Srivastava S; Pan J; Rai S; Petras RE; Ronquillo N; Polk HC; Galandiuk S
    Dis Colon Rectum; 2021 Sep; 64(9):1083-1095. PubMed ID: 33990498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Survival Benefits of 5-Fluorouracil-Based Adjuvant Chemotherapy for Patients With Microsatellite-Stable Stage III Colorectal Cancer According to the Tumor Budding Status: A Retrospective Analysis.
    Yamadera M; Shinto E; Kajiwara Y; Mochizuki S; Okamoto K; Hase K; Yamamoto J; Ueno H
    Dis Colon Rectum; 2019 Nov; 62(11):1316-1325. PubMed ID: 31567925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Multicenter Phase II Study on the Feasibility and Efficacy of S-1 and Oxaliplatin Neoadjuvant Chemotherapy for Locally Advanced Rectal Cancer.
    Sakamoto Y; Morohashi H; Miura T; Tsutsumi S; Takahashi S; Hirama K; Wakiya T; Hakamada K
    Dis Colon Rectum; 2022 May; 65(5):663-671. PubMed ID: 33833145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial Clinical Outcomes Using Umbilical Cord-Derived Tissue Grafts to Repair Anovaginal Fistula.
    Godoy-Brewer GM; Owodunni OP; Parian AM; Duraes LC; Selaru FM; Gearhart SL
    Dis Colon Rectum; 2023 Feb; 66(2):299-305. PubMed ID: 35001050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
    Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
    Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Prognostic Value of Lavage Cytology in Colorectal Cancer.
    Matsui S; Fukunaga Y; Sugiyama Y; Iwagami M; Nagasaki T; Akiyoshi T; Konishi T; Kawachi H
    Dis Colon Rectum; 2022 Jul; 65(7):894-900. PubMed ID: 34775412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.